ArticlePloS one2022

The anticoagulation length of therapy and risk of new adverse events in venous thromboembolism (ALTERNATIVE) study: Design and survey results.

Cecilia Portugal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.